| Sayali Oak, PHARMD | |
|
2800 Main St, Bridgeport, CT 06606-4292 | |
| (203) 576-5713 | |
| Not Available |
| Full Name | Sayali Oak |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2800 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669061248 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0015299 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sayali Oak, PHARMD 2800 Main St, Bridgeport, CT 06606-4292 Ph: (203) 576-5713 | Sayali Oak, PHARMD 2800 Main St, Bridgeport, CT 06606-4292 Ph: (203) 576-5713 |
News Archive
Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.
Delays in the launch and execution of critical market research projects can slow down the decision-making process, resulting in missed opportunities and increased costs. It is, therefore, absolutely critical for biopharmaceutical companies to develop a tactical approach to expedite the market research approval process for quicker and more meaningful insights.
A team of researchers led by Richard Slatcher, Ph.D., associate professor of psychology in the College of Liberal Arts and Sciences at Wayne State University, has been awarded $2.74 million from the National Heart, Lung and Blood Institute of the National Institutes of Health for a project that aims to improve asthma management in youth.
"Abruptly discontinuing co-trimoxazole - an antibiotic used to prevent opportunistic infections in HIV-positive people - can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.
Researchers at UCLA report that they have refined a method they previously developed for capturing and analyzing cancer cells that break away from patients' tumors and circulate in the blood. With the improvements to their device, which uses a Velcro-like nanoscale technology, they can now detect and isolate single cancer cells from patient blood samples for analysis.
› Verified 7 days ago
Dr. Yeganeh Ragati Haghi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1060 E Main St, Bridgeport, CT 06608 Phone: 203-382-0009 | |
Yujin Hong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4531 Main St, Bridgeport, CT 06606 Phone: 203-372-6538 Fax: 844-411-6470 | |
Ju-sung Song, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 960 North Ave, Bridgeport, CT 06606 Phone: 203-334-6978 | |
Dr. Lena Devietro, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3252 | |
Paul Joseph Piazza, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3252 Fax: 203-384-3625 | |
Dr. Lauren Michelle Dietrich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-6227 | |
Kevin Ehl, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Park Ave, Bridgeport, CT 06604 Phone: 203-696-0127 |